TrialThe British journal of dermatology2024

Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trial.

Eva Grekowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.